Welcome to our dedicated page for Alexandria Real Estate Eq news (Ticker: ARE), a resource for investors and traders seeking the latest updates and insights on Alexandria Real Estate Eq stock.
Alexandria Real Estate Equities, Inc. reports news as a life science real estate investment trust that owns, operates and develops collaborative Megacampus™ ecosystems in major life science innovation clusters. Company updates commonly cover operating results, funds from operations, leasing activity, rental-rate trends and property-market demand across locations such as Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City.
Recurring announcements also include quarterly common stock dividends, balance-sheet and liquidity commentary, capital recycling activity, senior note offerings, cash tender offers for outstanding debt and corporate governance or leadership matters tied to the REIT’s public-company structure.
Alexandria Real Estate Equities (NYSE: ARE) was ranked 16th in talent readiness among all S&P 500 companies in The Wall Street Journal's inaugural "Best Companies for the Future" list and was the highest-ranked equity REIT in this category.
The recognition highlights Alexandria's people-first culture, long-tenured leadership averaging 15 years, strong internal advancement, comprehensive development programs and a benefits package that includes 100% company-paid medical premiums and the Alexandria Lifeline™ specialized-care offering.
Alexandria Real Estate Equities (NYSE: ARE) highlights its long-term role building New York City's commercial life science ecosystem and investing in early-stage biotech through Alexandria Venture Investments.
The firm is cited as the second most active institutional life science investor in NYC and showcases exits including Petra Pharmaceuticals' 2020 sale to Eli Lilly and Intra-Cellular Therapies' $14.6 billion acquisition by Johnson & Johnson in 2025.
Alexandria Real Estate Equities (NYSE: ARE) declared a quarterly cash dividend of $0.72 per common share for 2Q26. The dividend is payable on July 15, 2026 to shareholders of record on June 30, 2026.
The $0.72 dividend matches the prior quarter, implying a 5.8% yield based on the May 28, 2026 close and a 42% dividend payout ratio for the three months ended March 31, 2026.
Alexandria Real Estate Equities (NYSE:ARE) will hold its second quarter 2026 operating and financial results conference call and webcast on Tuesday, August 4, 2026 at 2:00 p.m. ET.
Results will be released after market close on Monday, August 3, 2026, with live and replay access by phone and webcast.
Alexandria Real Estate Equities (NYSE: ARE) highlighted the impact of its longstanding partnership with the Navy SEAL Foundation, focusing on support for the Warrior Fitness Program.
The 19,188-square-foot San Diego facility, opened in November 2023 with Alexandria’s backing, delivers individualized, multidisciplinary care to active-duty SEALs, SWCCs, reservists and veterans. Demand for the program has risen 67% over two years, serving 206 warriors in 2023, 319 in 2024 and 344 in 2025. According to Alexandria, 2024 participants recorded average cognitive score improvements of 11.8 points for active duty and 9.8 points for veterans, along with reported gains in physical health, sleep, pain reduction and overall well-being.
Alexandria Real Estate Equities (NYSE: ARE) announced that founder and executive chairman Joel S. Marcus will receive the Richard J. Bolte Sr. Award on May 6, 2026.
Highlights: founded 1994 with $19M Series A; $20.44B market cap; 35.8 million RSF operating asset base as of March 31, 2026; partnership launching the MAP-D precision medicine depression study.
Alexandria Real Estate Equities (NYSE: ARE) reported 1Q26 diluted net income per share of $2.10 and 1Q26 FFO per share—diluted, as adjusted—of $1.73. Operating occupancy was 87.7%, net operating income (cash basis) was $1,672M (quarter annualized, down 15.2% vs. 1Q25), and leasing volume totaled 647,356 RSF in 1Q26. Liquidity was $4.17B, dispositions guidance midpoint is $2.9B for 2026, and quarter-annualized net debt and preferred stock to Adjusted EBITDA was 6.8x.
Management expects occupancy and same-property performance to improve in 2H26 as leased-but-not-yet-delivered space (~1.1M RSF) is delivered.
Land & Buildings issued an investment opinion on Welltower (NYSE:WELL) alleging the company’s Ten‑Year Executive Program transfers substantial shareholder value to management.
Key figures: at $300/share the CEO’s maximum award is ~8,698,012 units (~$2.6B); performance cap at $350 implies ~$3.04B plus $110–$240M distributions; estimated CEO accrual ~$1B six months in. WELL trades at 33x forward FFO vs a 5‑year average of 25x and an estimated 144% premium to NAV; Land & Buildings estimates ~35%–60% downside to peer valuations.
Alexandria Real Estate Equities (NYSE: ARE) was named one of the Most Trustworthy Companies in America by Newsweek for the fourth consecutive year on April 2, 2026. The company ranked second in the real estate and housing category and emphasizes strong tenant relationships, a long-tenured management team, and a flexible balance sheet.
Key metrics cited include 53% of annual rental revenue from investment-grade or large-cap tenants, 78% of rental revenue from Megacampus ecosystems, 82% of 2025 leasing from existing tenants, and a 466,598 RSF Novartis Biomedical Research Center groundbreaking in February 2026.
Alexandria Real Estate Equities (NYSE: ARE) was named one of the inaugural "Most Charitable Companies in America" by Newsweek on March 11, 2026. The recognition reflects survey results and analysis of philanthropy, community support, volunteering, media sentiment, and social impact metrics.
Alexandria highlights multi-year trust recognitions and its CSR focus areas, including medical innovation, mental health, military support, agtech, addiction treatment, and education partnerships.